Idera Pharmaceuticals, Inc.(NASDAQ : IDRA)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-2.32%||10.52||0.7%||$735.39m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.60%||201.58||1.9%||$414.73m|
|GILD||Gilead Sciences, Inc.||-2.21%||68.29||1.0%||$401.30m|
|REGN||Regeneron Pharmaceuticals, Inc.||-1.46%||574.61||2.7%||$353.89m|
|NTLA||Intellia Therapeutics, Inc.||3.53%||141.85||2.3%||$263.90m|
|CRSP||CRISPR Therapeutics AG||1.70%||121.02||0.6%||$144.72m|
|EXAS||EXACT Sciences Corp.||-3.64%||107.84||18.1%||$123.59m|
Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.